PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 14217257

CHRONIC ULCERATIVE COLITIS BEFORE AND AFTER COLECTOMY.

W ADDLEMAN
View original source ↗Export metadata ↓

Abstract

There is a proper time to advise removal of the colon and creation of a permanent ileostomy in the course of progressive toxic ulcerative colitis. When a thorough trial of medical therapy, including corticosteroids, has failed to halt progression of the disease, a properly timed colectomy may give the patient a new lease on life and enable him to maintain himself socially and economically.The development of ileostomy (Q-T) clubs has been an important factor in preparing them for and sustaining these young patients through the psychological trauma of an ileostomy. Two patients are described who illustrate the value of properly timed surgery and the contribution that ileostomy clubs can make.

Explore related subjects

ColectomyColitis, UlcerativeGlucocorticoidsHumansIleostomyMaleCOLITIS, ULCERATIVEILEOSTOMYJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W ADDLEMAN. 1964-10-31. CHRONIC ULCERATIVE COLITIS BEFORE AND AFTER COLECTOMY.. https://pubmed.ncbi.nlm.nih.gov/14217257/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Evolution of the technique in the transanal pull-through for Hirschsprung's disease: effect on outcome.

BACKGROUND: The transanal pull-through has become the standard operation for Hirschsprung's disease in many pediatric surgical centers. Over the past 8 years, we have modified our technique by leaving a short-rather than a long-rectal cuff and by doing routine intraabdominal colonic biopsies through an umbilical incision before beginning the anal dissection. The aim of this study was to determine if these modifications have changed the outcome for children undergoing this operation. METHODS: A retrospective cohort study of all patients who underwent transanal pull-through by a single surgeon between 1997 and 2005 was conducted. RESULTS: There were 23 children who had a long cuff (10-15 cm) and 22 who had a short cuff (<2 cm). The short cuff group tended to be younger (25 +/- 23 vs 139 +/- 67 days; P < .05) and smaller (3.5 +/- 0.7 vs 6.0 +/- 2.7 kg; P < .05) at the time of surgery. The operating time was shorter (167 vs 186 minutes; P = .05) in the short cuff group. Outcomes were improved in the short cuff group, as evidenced by decreased hospital stay (1.9 +/- 0.6 vs 2.7 +/- 0.9; P < .05), decreased incidence of enterocolitis (9% vs 30%; P = .1), and lower incidence of narrowing requiring daily dilatations (5% vs 30%; P < .05). Preliminary colonic biopsy was performed on 18 of the 45 patients. This had no significant effect on narcotic use (66% vs 70%; P = .8) and did not increase operating time (174 +/- 31 vs 179 +/- 34 minutes; P = .6). Hospital stay was shorter in the umbilical biopsy group (1.9 +/- 0.6 vs 2.6 +/- 0.9 days; P = .006). CONCLUSION: Results of the transanal pull-through have improved likely as a result of a combination of experience and use of a shorter rectal muscular cuff. The use of a preliminary colonic biopsy through an umbilical incision has not increased postoperative pain, prolonged operative time, or lengthened hospital stay.

Colectomy↗
PubMed2007

Intestinal surgery in advanced ovarian cancer.

PURPOSE OF REVIEW: This review examines the current role of intestinal surgery in advanced ovarian cancer. Institutions differ considerably in surgical procedures and therapeutic outcomes for this disease. Moreover, therapeutic outcomes are influenced by the inclusion criteria for surgical procedures and the degree of surgical completion. We discuss the role of intestinal surgery and suggest surgical indications for intestinal surgery in advanced ovarian cancer. RECENT FINDINGS: Prognosis in advanced ovarian cancer is better when there is a smaller postoperative tumor mass. However, it is necessary to investigate the effects of intestinal surgery on residual tumor mass and its prognostic benefits. Here, recent reports were reviewed to ascertain the usefulness and safety of intestinal surgery for advanced ovarian cancer and examine surgical indications and institutional requirements. SUMMARY: By performing aggressive intestinal surgery such as combined bowel resection, optimal cytoreductive surgery can be performed in 70-98% of cases. The morbidity associated with intestinal surgery is acceptably low. Prognostic benefits for intestinal surgery are clear in patients with operable ovarian cancer with no residual disease. Women with suspected ovarian cancer should therefore be referred to centers with experienced tumor surgeons.

Colectomy↗